It has been 6 weeks since the FDA has allowed the

It has been 6 weeks since the FDA has allowed the open label trial extension and expedited EIND. Cytodyn has to approve each and every request and supply the drug for them. They must know how many they have approved. If it is a large number the implications are clear. This is important information which we as as share holders and the public deserve to know as it becomes available. It is a window into the thinking of the treating physicians. I hope that management shares that important information with us in a timely manner.